Document:

Director Compensation Schedule

 Exhibit 10(x) 
 INVACARE CORPORATION 
 BOARD OF DIRECTORS COMPENSATION

  

							
	 Retainer Fee
	  	$	60,000	  	  	
	 Additional Retainer Fees
	  				  	
	 Lead Director:
	  	$	15,000	  	  	
	 Audit Chair:
	  	$	15,000	  	  	
	 Compensation Chair:
	  	$	15,000	  	  	
	 Other Committee Chairs:
	  	$	10,000	  	  	
	 Fees for Meetings in excess of 24 in a year
	  	$	1,500	  	  	
		
	 Equity Components
	  	 	Restricted stock award grant value of $90,000
		
		  	 
 	For new directors - non-qualified stock option grant equal to
$150,000 divided by the market price on date elected
		
	 Non-Employee Director Elective Stock Option Program
	  	 
 	Non-employee directors may elect to defer all or a portion of their
following year director fees into discounted stock optionsForm of Rule 10b5-1 Sales Plan

 Exhibit 10(ab) 
 Rule 10b5-1 Sales Plan 
 I,
                    , have, as of the date set forth below, established this Sales Plan (the “Plan”) in order to sell to Invacare
Corporation (the “Issuer”) common shares, no par value per share, of the Issuer (the “Stock”), pursuant to the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”). 
 1. I elect to surrender shares of Stock to the Issuer in order to satisfy the minimum tax withholding obligation required by
federal, state and local governmental authorities (including such amount, if any, as may be required under the American Jobs Creation Act of 2004) with respect to the shares of Stock I will receive on the respective maturity dates of the restricted
stock grants currently outstanding and issued to me, and any restricted stock grants that are issued to me in the future by the Issuer, as indicated on Attachment A to the Plan. 
 2. On each respective maturity date set forth or described on Attachment A hereto, the Issuer agrees to withhold such portion of the restricted stock maturing on such date as is necessary to satisfy such
minimum tax withholding obligation required by federal, state and local governmental authorities based on the rates in effect on the applicable maturity date at a price per share equal to the closing price of the Stock on the New York Stock Exchange
on the applicable maturity date. 
 3. The Plan will terminate on the earliest of: 

a. the completion of the maturity or the termination of the restricted stock grants currently outstanding and issued to me and any
restricted stock grants that are issued to me in the future by the Issuer, as referenced in Section 1 of the Plan; 
 b. the
Issuer’s receipt of notice of my death or mental incapacity; 
 c. the Issuer’s reasonable determination that:
(i) the Plan does not comply with Rule 10b5-1 or other applicable securities laws; or (ii) I have not complied with the Plan, Rule 10b5-1 or other applicable securities laws; 

d. the Issuer’s receipt of written notice of termination from me by overnight service and facsimile certifying that I desire to
terminate the Plan and have consulted with my legal advisors about the termination of the Plan; 
 e. the Issuer’s receipt
of notice from me by telephone or facsimile specifying that a legal, contractual or regulatory restriction applicable to me or my affiliates would prohibit any sale pursuant to the Plan or result in material adverse consequences to me as a result of
any such sale, or 
 f. the public announcement of a public offering or other distribution of securities by the Issuer or of a
merger, acquisition, tender or exchange offer, or other business combination resulting in the exchange or conversion of the Stock of the Issuer into shares of a company other than the Issuer. 
 4. In the event of a stock split, reverse stock split or stock dividend relating to the Stock, the dollar amount at which shares of Stock are to be surrendered to the Issuer and the number of shares to be
surrendered will be automatically adjusted proportionately. 
 5. In the event of a reincorporation or other corporate reorganization resulting
in an automatic share-for-share exchange of new shares for the type of shares of Stock subject to the Plan, then the new shares will automatically replace the type of shares of Stock originally specified in the Plan. 

6. The Plan may be modified or amended only upon the written agreement of myself and the Issuer. 

7. The Plan may be signed in counterparts, each of which will be an original. I will not assign my rights or obligations under the Plan without the
Issuer’s consent. 
 8. The Plan, and the attached Representation Letter, dated the date hereof, constitutes the entire agreement and Plan
between me and the Issuer and supersedes any prior agreements or understandings regarding the Plan. The invalidity or unenforceability of any provision of the Plan will not affect the validity or enforceablity of any other provision. 

 9. All notices given by the parties under this Plan will be made in the manner specified in this Plan by
telephone, facsimile or recognized overnight service as follows: 
  

	 	a.	If to the Issuer: 

Invacare Corporation 
 Attn: Robert K. Gudbranson 
 One Invacare Way 

Elyria, OH 44036 
 Tel: 440-329-6111 
 Fax: 440-366-9008 

 

	 	b.	If to me: 

____________ 
 ____________ 
 ____________ 

Tel:
                     
 Fax:                     . 
 10. This Plan will be governed by and construed in accordance with the laws of the State of Ohio, without giving effect to the conflict of law principles of that State. 

The undersigned have signed this Sales Plan as of         
         . 
  

									
	 	 		 	Invacare Corporation (the Issuer)
	 Name:

 
	 		 		 	  
 By:
	 	 
		 		 		 	Name:	 	
		 		 		 	Title:	 	

  
 2 

 Rule 10b5-1 Representation Letter 
 Invacare Corporation 
 Attn: Robert K. Gudbranson 

One Invacare Way 
 Elyria, OH 44036 

Ladies and Gentlemen: 
 In
consideration of Invacare Corporation (“Invacare”) agreeing to accept the surrender of Invacare common shares from the restricted stock maturing in order to satisfy my minimum tax withholding obligation for federal, state and local taxes
under a written plan (the “Plan”) that I,                     , have established to meet the requirements of Rule 10b5-1(c)(1) under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and other good and valuable consideration I make the following representations, warranties and covenants: 
 1. A true and accurate copy of the Plan is attached. 
 2. I am entering into the Plan in good
faith, in compliance with the requirements of Rule 10b5-1, and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1 or other federal securities laws. As of the date hereof, I am not aware of any material nonpublic information
about Invacare or its securities. 
 3. I have consulted with my own advisors as to the legal, tax, business, and financial aspects of, and have
not relied on Invacare in connection with, my adoption and implementation of the Plan and I have confirmed that the Plan meets the criteria set forth in Rule 10b5-1. I acknowledge that Invacare is not acting as a fiduciary or an advisor for me.

 4. I have been or will be granted all restricted shares that are subject to the Plan free and clear of liens, encumbrances, options or other
limitations on disposition of any kind. 
 5. While the Plan is in effect, I agree that: 

a. I will not enter into or alter any corresponding or hedging transaction or position with respect to the securities covered by the Plan
(including, without limitation, with respect to any securities convertible or exchangeable into those securities) and I will not alter or deviate from the terms of the Plan; and 

b. I will notify Invacare in advance of any sales or purchases of, or derivative transactions on, any of the Invacare securities that I
propose to make. 
 6. Except as provided under the terms of the Plan, I further agree that I will not exercise any subsequent influence over
how, when or whether transactions are effected under the plan. 
 7. I agree to make or cause to be made in a timely manner all necessary
filings applicable to me, including Rule 144 filings, filings pursuant to Sections 13 and 16 of the Exchange Act, and any other filings necessary pursuant to the Securities Act of 1933, as amended (the “Securities Act”) and the Exchange
Act. 

 8. The execution and delivery of the Plan by me and the transactions contemplated by the Plan will not
contravene any provision of applicable law or any agreement or other instrument binding on me or any of my affiliates or any judgment, order or decree of any governmental body having jurisdiction over me or my affiliates. 

9. I agree to give Invacare notice as soon as possible of (a) any subsequent legal, contractual or regulatory restrictions imposed on me due to
changes in the securities (or other) laws, contractual restrictions, or anticipated or changed events, that would prevent Invacare or me from complying with the Plan and (b) the occurrence of any event that could cause the Plan to terminate or
be suspended under Section 2 or Section 3 of the Plan. 
  

			
	Very truly yours,
		
	Name:	 	 
	Date:	 	

 Schedule of Agreements with Current Officers 

 

					
	 Name
	  	 Position
	  	Date of Agreement
	 A. Malachi Mixon, III
	  	Chairman of the Board	  	August 7, 2007
	 Gerald B. Blouch
	  	President and Chief Executive Officer	  	August 6, 2007
	 Robert K. Gudbranson
	  	Senior Vice President and Chief Financial Officer	  	February 2, 2009
	 Brian Ellacott
	  	Vice President & General Manager – Commercial Operations, Americas	  	August 7, 2007
	 Doug Harper
	  	Vice President & General Manager - Invacare Supply Group	  	August 8, 2007
	 Joseph B. Richey, II
	  	President - Invacare Technologies, Senior Vice President - Electronics and Design Engineering	  	August 13, 2007
	 Louis F. J. Slangen
	  	Senior Vice President – Corporate Marketing and Chief Product Officer	  	August 6, 2007
	 Carl E. Will
	  	Senior Vice President – Commercial Operations	  	August 7, 2007
	 Anthony C. LaPlaca
	  	Senior Vice President - General Counsel and Secretary	  	November 30, 2009
	 Patricia Stumpp
	  	Senior Vice President – Human Resources	  	February 8, 2011
	 John Remmers
	  	Senior Vice President – Global Supply Chain and Operations	  	February 8, 2011

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00185-of-00352.parquet"}]]